ORs for SLE patients with different Hsp70-4 genotypes and haplotypes (Hsp70-4 and -5) based on the presence of anti-Ro and anti-La autoantibodies
Population: Hsp70-4 genotypes | Autoantibodies against | p Value | OR | 95% CI |
---|---|---|---|---|
Erlangen | Ro | |||
C/C versus T/T | 0.02 | 2.74 | 1.15 to 6.52 | |
C/C versus C/T | 0.02 | 2.15 | 1.12 to 4.13 | |
La | ||||
C/C versus T/T | 0.02 | 3.01 | 1.18 to 7.70 | |
C/C versus C/T | NS | 1.36 | 0.63 to 2.97 | |
OMRF | Ro | |||
C/C versus T/T | NS | 1.27 | 0.68 to 2.37 | |
C/C versus C/T | 0.03 | 1.67 | 1.04 to 2.68 | |
La | ||||
C/C versus T/T | 0.02 | 2.73 | 1.12 to 6.65 | |
C/C versus C/T | 0.001 | 3.24 | 1.53 to 6.88 |
Population: haplotypes (Hsp70-4 and Hsp-5) | Autoantibodies against | p Value | OR | 95% CI |
---|---|---|---|---|
Erlangen | Ro | |||
C–G/C–G versus T–G/T–G | 0.004 | 5.14 | 1.57 to 16.84 | |
C–G/C–G versus C–G/T–G | 0.001 | 3.21 | 1.58 to 6.53 | |
La | ||||
C–G/C–G versus T–G/T–G | 0.01 | 4.17 | 1.29 to 13.55 | |
C–G/C–G versus C–G/T–G | NS | 1.91 | 0.85 to 4.29 | |
OMRF | Ro | |||
C–G/C–G versus T–G/T–G | NS | 1.65 | 0.78 to 3.50 | |
C–G/C–G versus C–G/T–G | NS | 1.65 | 0.97 to 2.69 | |
La | ||||
C–G/C–G versus T–G/T–G | 0.05 | 2.72 | 0.97 to 7.66 | |
C–G/C–G versus C–G/T–G | 0.007 | 2.81 | 1.30 to 6.05 |
ORs were calculated using χ2 test.
OMRF, Oklahoma Medical Research Foundation; SLE, systemic lupus erythematosus.